对儿童喘管理的综合性方法:案例研究
Rekha V Shinde1, Ashish Varma2, Saurabh Deshmukh3
1Department of Kaumarbhritya, DMAMCH and RC, Wanadongri, Hingna, Nagpur, MUHS Nashik, Maharashtra, India.
Journal of pharmacy & bioallied sciences
|June 13, 2025
概括
这项案例研究表明,将传统医学与补充疗法结合起来,显著改善了儿童喘的结果. 综合性方法改善了年轻患者的肺功能和幸福感.
科学领域:
- 儿科 儿科 儿科
- 综合医学是一个整体的医学.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 儿童喘是一种慢性呼吸道疾病,需要全面管理.
- 有效的喘控制旨在减少恶化并改善患者的生活质量.
- 传统治疗可以通过补充疗法来增强,以获得更好的结果.
研究的目的:
- 探索一个整合性的方法来管理儿童喘.
- 评估结合传统和补充疗法对儿科喘患者的影响.
- 突出个性化,多学科护理在慢性呼吸道疾病管理中的好处.
主要方法:
- 一个整体的治疗计划被开发为一个9岁的女孩中度持续性喘.
- 该计划包括药物治疗 (吸入皮质类固醇,支气管扩展剂),饮食改变,运动和心身干预 (,呼吸练习).
- 实施了环境控制措施,以尽量减少过敏原和触发剂的暴露.
主要成果:
- 患者的肺功能显著改善.
- 观察到喘发作的频率和严重程度显著减少.
- 报告说,改善了整体福祉和生活质量.
结论:
- 结合常规和补充疗法的综合方法在儿童喘管理方面显示出前景.
- 个性化,多学科的护理对于有效管理儿童喘等慢性疾病至关重要.
- 该研究支持将补充疗法整合到传统医疗框架中,以改善患者的治疗结果.
更多相关视频
相关概念视频
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
374
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
374
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


